Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.23.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2022
Dec. 31, 2021
Assets    
Cash and cash equivalents $ 3,173 $ 21,729
Restricted cash 6,300 7,213
Accounts receivable, net 6,744 6,792
Inventories, net 10,257 5,245
Prepaid expenses and other current assets 1,051 2,940
Total Current Assets 27,525 43,919
Fixed assets, net 375 369
Right-of-use assets, operating leases 173 56
Intangible assets, net 10,059 11,586
Goodwill 0 18,614
Other assets 544 116
Total Assets 38,676 74,660
Current Liabilities    
Accounts payable 2,932 4,553
Accrued and other liabilities 2,596 1,879
Term loan, net 0 855
Operating lease liability 52 54
Total Current Liabilities 5,580 7,341
Non-current Liabilities    
Line of credit, net 11,444 4,856
Term loan, net 0 4,559
Deferred tax liability 0 24
Operating lease liability 124 5
Total Non-current Liabilities 11,568 9,444
Total Liabilities 17,148 16,785
Stockholders’ Equity    
Common Stock, $0.001 par value, 200,000,000 shares authorized, 29,430,267 & 29,146,367 shares issued and outstanding as of December 31, 2022 and 2021, respectively 29 29
Additional paid-in capital 320,071 317,102
Accumulated deficit (298,572) (259,256)
Total Stockholders’ Equity 21,528 57,875
Total Liabilities and Stockholders’ Equity $ 38,676 $ 74,660